Press release
Global Ophthalmic Drugs Market to Reach US$21.6 bn by 2018 due to High Incidence of Eye-related Disorders amongst Geriatrics
Browse the full Ophthalmic Drugs Market (Dry eye, Anti-glaucoma, Anti-allergy/inflammatory/infective, Retinal Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018 report at http://www.transparencymarketresearch.com/ophthalmic-drugs-market.html
According to the research report, the global ophthalmic drugs market was valued at US$16 bn in 2012 and is estimated to reach a market value of US$21.6 bn by 2018, rising at a CAGR of 5.2% from 2013 to 2018. Ophthalmic drugs or ophthalmic medications refer to ointments, drops, or intraocular disks that are prescribed to patients with eye-related disorders. The remarkable growth of the global ophthalmic drugs market in the last few years is related to the high incidence of eye disorders due to the increasing number of diabetics, the growing pool of the aging population, and macular degeneration. The significant number of technological advancements in drug delivery techniques and increasing awareness about and prevalence of lifestyle-related diseases are also propelling the global ophthalmic drugs market.
The global ophthalmic drugs market is segmented on the basis of type, treatment drug, and geography. The types of drugs in this market are OTC drugs and prescription drugs. On the basis of treatment drug, this market is segmented into retinal drugs, dry eye drugs, anti-inflammatory or allergy or infective drugs, and anti-glaucoma drugs. Geographically, this market is segmented into Europe, North America, Asia Pacific, and Rest of the World. Amongst treatment drugs, the anti-glaucoma drugs segment is leading the global ophthalmic treatment drugs market, with a CAGR of 4.2% expected during the mentioned forecast period.
In terms of regions, North America dominates the overall ophthalmic drugs market and is likely to maintain its dominance due to the growing initiatives to prevent blindness and other disorders related to the eyes amongst the aging population. During the same forecast period of 2013-2018, the ophthalmic drugs market in Asia Pacific is also expected to witness strong growth due to the increasing ophthalmic disorders amongst geriatrics in the region. Countries such as China, India, and others in Southeast Asia are expected to be the largest consumers of these drugs, thereby propelling the ophthalmic drugs market in Asia Pacific.
Some of the key players in the global ophthalmic drugs market are Santen Pharmaceutical Co. Ltd., Merck & Co. Inc., Roche Holding AG, Pfizer Inc., Allergan Inc., and Novartis International AG. Presently, Novartis leads the global ophthalmic drugs market with a share of 24% in the overall market as of 2012. The research report provides a detailed analysis of the competitive landscape of the global ophthalmic drugs market and the regulatory framework influencing the overall market. Additionally, the report also explains the research and development activities, financial overview, investment outlook, and product portfolio of these top players.
The global ophthalmic drugs market is segmented into:
By Types
Prescription Drugs
OTC Drugs
By Treatment Drugs
Dry Eye Drugs
Retinal Drugs
Anti-inflammatory/allergy/infective Drugs
Anti-glaucoma Drugs
By Regions
North America
Europe
Asia Pacific
Rest of the World (RoW
Download Exclusive Sample of This Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1769
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact
Mr.Sudip S
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Ophthalmic Drugs Market to Reach US$21.6 bn by 2018 due to High Incidence of Eye-related Disorders amongst Geriatrics here
News-ID: 419856 • Views: …
More Releases from Transparency Market Research - Pharmaceutical
Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Global Neurovascular Devices Market: Overview
The global population is aging rapidly. According to WHO, the chances of health risks are greater in geriatric people than the young generation. Old age is considered to be one of the biggest risk factors that are responsible for developing various diseases such as cardiovascular and neurological conditions. It is because of these factors, the global neurovascular devices market is experiencing robust growth in the…
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2 …
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise…
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from …
Swab and Viral Transport Medium Market:
Introduction
Transparency Market Research has published a new report titled, ‘Global Swab and Viral Transport Medium Market ’. According to the report, the global swab and viral transport medium market was valued at US$ 0.9 Bn in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030. Viral transport medium (VTM) enables safe transfer of viruses, chlamydia, and mycoplasma for…
Radiofrequency Ablation Devices Market by Product, Geography and Forecast to 202 …
Transparency Market Research (TMR) has published a new report titled, 'Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027.
Overview
Radiofrequency ablation is a minimally invasive surgical…
More Releases for Drugs
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
Prospect of Global Excipients Market Research Report 2017 with Application inclu …
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database.
In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),…
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests.
On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.…
